CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...